Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Avacta Group Share News (AVCT)
AVCT Share
Price
AVCT Share
News
AVCT Share
Chat36
AVCT Share
Trades196
AVCT
Live RNS
AVCT Share
Charts
AVCT Level 2
Console
AVCT Live
Share Price
AVCT Broker
Ratings
AVCT Directors
Deals
AVCT Financial
Diary
AVCT
Fundamentals
AVCT Short
Positions
AVCT
Media
AVCT Company
Research
AVCT Company
Timeline
Share Price Information for Avacta Group (AVCT)
Last checked at -
Last checked at 
Intraday Avacta Group Share Chart
Avacta Group News
Avacta Non-Executive Sam Williams Steps Down After General Meeting
Avacta Non-Executive Sam Williams Steps Down After General Meeting
Avacta Plans GBP9 Million Fundraise; Loss Widens On Research Costs
Avacta Plans GBP9 Million Fundraise; Loss Widens On Research Costs
Avacta Teams With ADC Therapeutics To Develop Affimer-Drug Conjugates
Avacta Teams With ADC Therapeutics To Develop Affimer-Drug Conjugates
Avacta inks collaboration deal with ADC Therapeutics
(Sharecast News) - Biotechnology company Avacta Group has entered a collaboration and option agreement with ADC Therapeutics, which it described as a ...
Avacta partners with Selexis ahead of first-in-human trials
(Sharecast News) - Avacta Group announced on Thursday that it has partnered with life sciences company Selexis to develop the Chinese hamster ovary (C...
Avacta Selects Candidate For First Human Trials Of Affimer Platform
LONDON (Alliance News) - Avacta Group PLC on Monday said it has selected a clinical development candidate AVA004 for first-time-in-human clinical tria...
Avacta To Submit Application For TMAC Linker Testing In Tumours Study
LONDON (Alliance News) - Avacta Group PLC on Monday said it is planning to submit an application to test its TMAC linker in patients with selected sol...
Avacta falls as stuttering revenues exacerbate losses
(Sharecast News) - Avacta Group's shares slid on Tuesday as interim revenues dropped on the back of a lower contribution from the life sciences divisi...
Follow the stocks
